EichorEICHOR
Condition: Finerenone Synced from ClinicalTrials.gov · August 05, 2026

Recruiting studies: Finerenone

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Efficacy and Safety of Finerenone Compared to Spironolactone in Treatment of Primary Aldosteronism
NA · 1 location(s) · Bangladesh Medical University · NCT07688928The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
Phase 3 · 43 location(s) · The George Institute · NCT06058585A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide
Phase 3 · 1 location(s) · Sarfez Pharmaceuticals, Inc. · NCT07223502The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study
Phase 2 · 1 location(s) · University of North Carolina, Chapel Hill · NCT06059664An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is a
Phase N/A · 4 location(s) · Bayer · NCT06278207Efficacy and Safety of Finerenone in Patients With Primary Membranous Nephropathy
Phase 4 · 1 location(s) · First Affiliated Hospital, Sun Yat-Sen University · NCT06573411Finerenone in Patients With IgA-nephropathy: Prospective Interventional Trial
NA · 1 location(s) · Botkin Hospital · NCT07056595Finerenone for Patients With Primary Aldosteronism (FAIRY)
Phase 4 · 1 location(s) · Qifu Li · NCT06457074A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, a
Phase 3 · 164 location(s) · Bayer · NCT05196035Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure
Phase 4 · 21 location(s) · Juntendo University · NCT07397650A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure P
Phase 3 · 315 location(s) · Colorado Prevention Center · NCT06008197A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Bo
Phase 3 · 133 location(s) · Bayer · NCT07188805Effect of Treatment With Finerenone on Cardio-Renal Target Organ Damage in Patients With Type 2 Diabetes.
Phase 4 · 1 location(s) · University of Aarhus · NCT07026539A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · 132 location(s) · Bayer · NCT07192952A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor
Phase 3 · 179 location(s) · Bayer · NCT05457283A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · 176 location(s) · Colorado Prevention Center · NCT06033950Finerenone Therapy for Pediatric HSPN With Mild Proteinuria
Phase 4 · 1 location(s) · Capital Institute of Pediatrics, China · NCT07315191An Observational Study, Called FINEXPLORER, to Learn More About How Well Finerenone Works in Adults in Spain With Chroni
Phase N/A · 1 location(s) · Bayer · NCT07554469An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic
Phase N/A · 1 location(s) · Bayer · NCT07232537A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · 104 location(s) · Colorado Prevention Center · NCT06024746A Study to Learn More About How Safe Finerenone is and How Well it Works in Adults With Chronic Heart Failure in South K
Phase N/A · 1 location(s) · Bayer · NCT07379840Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Phase 2 · 2 location(s) · Peter Rossing · NCT06906081Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease
Phase N/A · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT06838416
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.